Surprise win for anti-inflammatory heart drug boosts Novartis

04:42 EDT 22 Jun 2017 | Reuters

ZURICH/LONDON (Reuters) - A Novartis drug designed to reduce inflammation has shown surprising efficacy in cutting cardiovascular risk for people who had survived a heart attack, potentially changing ideas about treatment and boosting the company's s...

Original Article: Surprise win for anti-inflammatory heart drug boosts Novartis


More From BioPortfolio on "Surprise win for anti-inflammatory heart drug boosts Novartis"

Quick Search


Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...